BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32913963)

  • 1. Genomic Profiling to Expand Management Options for Locally Advanced Esophagogastric Cancers: A Proof of Principle Case.
    Klempner SJ; Wu W; Mehta P; Schrock AB; Chao J; Ali SM
    JCO Precis Oncol; 2017; 1():. PubMed ID: 32913963
    [No Abstract]   [Full Text] [Related]  

  • 2. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
    BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA; D'Amico TA; Bentrem DJ; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Farjah F; Gerdes H; Gibson M; Grierson P; Hofstetter WL; Ilson DH; Jalal S; Keswani RN; Kim S; Kleinberg LR; Klempner S; Lacy J; Licciardi F; Ly QP; Matkowskyj KA; McNamara M; Miller A; Mukherjee S; Mulcahy MF; Outlaw D; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian NR; Pluchino LA
    J Natl Compr Canc Netw; 2023 Apr; 21(4):393-422. PubMed ID: 37015332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.
    Staiger WI; Ronellenfitsch U; Kaehler G; Schildhaus HU; Dimitrakopoulou-Strauss A; Schwarzbach MH; Hohenberger P
    World J Surg Oncol; 2008 Apr; 6():37. PubMed ID: 18394167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Corvera C; Das P; Denlinger CS; Enzinger PC; Fanta P; Farjah F; Gerdes H; Gibson M; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Johung KL; Keswani RN; Kleinberg LR; Leong S; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Paluri RK; Park H; Perry KA; Pimiento J; Poultsides GA; Roses R; Strong VE; Wiesner G; Willett CG; Wright CD; McMillian NR; Pluchino LA
    J Natl Compr Canc Netw; 2019 Jul; 17(7):855-883. PubMed ID: 31319389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.
    Moehler M; Baltin CT; Ebert M; Fischbach W; Gockel I; Grenacher L; Hölscher AH; Lordick F; Malfertheiner P; Messmann H; Meyer HJ; Palmqvist A; Röcken C; Schuhmacher C; Stahl M; Stuschke M; Vieth M; Wittekind C; Wagner D; Mönig SP
    Gastric Cancer; 2015 Jul; 18(3):550-63. PubMed ID: 25192931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy.
    Wiwitkeyoonwong J; Jiarpinitnun C; Hiranyatheb P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3847-3855. PubMed ID: 34967563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal and esophagogastric junction cancers, version 1.2015.
    Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Besh S; Chao J; Das P; Denlinger C; Fanta P; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Jasperson K; Keswani RN; Kleinberg LR; Korn WM; Leong S; Lockhart AC; Mulcahy MF; Orringer MB; Posey JA; Poultsides GA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Washington MK; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H;
    J Natl Compr Canc Netw; 2015 Feb; 13(2):194-227. PubMed ID: 25691612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review.
    Shoji Y; Koyanagi K; Kanamori K; Tajima K; Ogimi M; Yatabe K; Yamamoto M; Kazuno A; Nabeshima K; Nakamura K; Nishi T; Mori M
    World J Gastroenterol; 2023 Jun; 29(24):3758-3769. PubMed ID: 37426325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.
    Chaudhary SP; Kwak EL; Hwang KL; Lennerz JK; Corcoran RB; Heist RS; Russo AL; Parikh A; Borger DR; Blaszkowsky LS; Faris JE; Murphy JE; Azzoli CG; Roeland EJ; Goyal L; Allen J; Mullen JT; Ryan DP; Iafrate AJ; Klempner SJ; Clark JW; Hong TS
    Oncologist; 2020 Nov; 25(11):e1691-e1700. PubMed ID: 32820577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present situation and prospect of immunotherapy for unresectable locally advanced esophageal cancer during peri-radiotherapy.
    Wang FM; Mo P; Yan X; Lin XY; Fu ZC
    World J Gastrointest Oncol; 2024 Jan; 16(1):1-7. PubMed ID: 38292836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world association of HER2/
    Stein SM; Snider J; Ali SM; Miksad RA; Alexander BM; Castellanos E; Schrock AB; Madison R; Swaminathan A; Venstrom JM; McCusker M
    Future Oncol; 2021 Nov; 17(31):4101-4114. PubMed ID: 34463133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma?
    Cartwright E; Keane FK; Enzinger PC; Hong T; Chau I
    Am Soc Clin Oncol Educ Book; 2018 May; 38():280-291. PubMed ID: 30231360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
    Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X
    BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.
    Haag GM; Byl A; Jäger D; Berger AK
    Oncology; 2017; 92(5):291-298. PubMed ID: 28249280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
    Shi J; Li N; Tang Y; Jiang L; Yang L; Wang S; Song Y; Liu Y; Fang H; Lu N; Qi S; Chen B; Li Z; Liu S; Wang J; Wang W; Zhu S; Yang J; Li Y; Zhao D; Jin J
    BMC Gastroenterol; 2022 Jul; 22(1):359. PubMed ID: 35902798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts.
    Moy RH; Walch HS; Mattar M; Chatila WK; Molena D; Strong VE; Tang LH; Maron SB; Coit DG; Jones DR; Hechtman JF; Solit DB; Schultz N; de Stanchina E; Janjigian YY
    JCO Precis Oncol; 2022 Feb; 6():e2100242. PubMed ID: 35138918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.
    Janjigian YY; Bendell J; Calvo E; Kim JW; Ascierto PA; Sharma P; Ott PA; Peltola K; Jaeger D; Evans J; de Braud F; Chau I; Harbison CT; Dorange C; Tschaika M; Le DT
    J Clin Oncol; 2018 Oct; 36(28):2836-2844. PubMed ID: 30110194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS].
    Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D
    Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature.
    Krishnamurthy A; Mohanraj N; Radhakrishnan V; John A; Selvaluxmy G
    Indian J Cancer; 2017; 54(4):646-651. PubMed ID: 30082551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.